Formulation design of dry powders for inhalation
Drugs for inhalation are no longer exclusively highly crystalline small molecules. They may
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
[引用][C] Formulation Design of Dry Powders for Inhalation
JG Weers, DP Miller - Journal of Pharmaceutical Sciences, 2015 - cir.nii.ac.jp
Formulation Design of Dry Powders for Inhalation | CiNii Research CiNii 国立情報学研究所 学術
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
Formulation Design of Dry Powders for Inhalation
JG Weers, DP Miller - Journal of Pharmaceutical Sciences, 2015 - jpharmsci.org
Drugs for inhalation are no longer exclusively highly crystalline small molecules. They may
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
[PDF][PDF] Formulation Design of Dry Powders for Inhalation
JG WEERS, DP MILLER - Journal of Pharmaceutical Sciences, 2015 - researchgate.net
Drugs for inhalation are no longer exclusively highly crystalline small molecules. They may
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
Formulation Design of Dry Powders for Inhalation.
JG Weers, DP Miller - Journal of Pharmaceutical Sciences, 2015 - europepmc.org
Drugs for inhalation are no longer exclusively highly crystalline small molecules. They may
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
Formulation Design of Dry Powders for Inhalation
JG Weers, DP Miller - Journal of Pharmaceutical Sciences, 2015 - Wiley Online Library
Drugs for inhalation are no longer exclusively highly crystalline small molecules. They may
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
Formulation Design of Dry Powders for Inhalation
JG Weers, DP Miller - Journal of pharmaceutical sciences, 2015 - pubmed.ncbi.nlm.nih.gov
Drugs for inhalation are no longer exclusively highly crystalline small molecules. They may
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
Formulation Design of Dry Powders for Inhalation
JG Weers, DP Miller - Journal of Pharmaceutical Sciences, 2015 - infona.pl
Drugs for inhalation are no longer exclusively highly crystalline small molecules. They may
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …